Mabgenex is founded with a vision to be a global leader in AI driven biologics. Our mission is to provide biologics as solutions to unmet needs in therapeutics and diagnostics. Mabgenex is working on replicating, at least in part, the complex process of selection of an antigen specific antibody, by combining biology with machine learning to generate antibodies with high specificity and sensitivity. At Mabgenex, we use a proprietary method to isolate specific antibodies that does not require conventional immunizations. Our method of antibody generation is efficient, effective, faster and cheaper. Using a combination of biology and Artificial Intelligence, the efficiency of clonal selection and optimization is significantly enhanced.

mAbGenEx develops precision single-domain antibody therapeutics for immuno-oncology and complex target biology using biology-aware AI/ML antibody discovery platforms.

Other business activities

Source: Ministry of Corporate Affairs company master (open data). Capital figures are as-of the 2021 registry snapshot, not live.

Extracted from Mabgenex India Private Limited's own website, fetched Jul 2026. Verification badges reflect format/MX checks, not endorsement.